Evidence map›Paper›PMID 38201846›Full record

Trial reportNutrients2023

Efficacy of Probiotic Supplements on Brain-Derived Neurotrophic Factor, Inflammatory Biomarkers, Oxidative Stress and Cognitive Function in Patients with Alzheimer's Dementia: A 12-Week Randomized, Double-Blind Active-Controlled Study.

Yu-Chieh Hsu, Yen-Yu Huang, Shin-Yu Tsai, Yi-Wei Kuo, Jia-Hung Lin, Hsieh-Hsun Ho, Jui-Fen Chen, Ko-Chiang Hsia, Yu Sun

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 7 pooled it
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 7 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Nutrients · 2025
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Efficacy and Safety ofNutrients · 2025
    Trial
  9. Trial
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yu-Chieh HsuDepartment of Research and Design, Glac Biotech Co., Ltd., Tainan 744, Taiwan.ORCID 0000-0003-3714-4262
Yen-Yu HuangDepartment of Research and Design, Glac Biotech Co., Ltd., Tainan 744, Taiwan.ORCID 0000-0003-3661-1949
Shin-Yu TsaiDepartment of Research and Design, Glac Biotech Co., Ltd., Tainan 744, Taiwan.
Yi-Wei KuoDepartment of Research and Design, Glac Biotech Co., Ltd., Tainan 744, Taiwan.ORCID 0000-0001-5107-426X
Jia-Hung LinDepartment of Research and Design, Glac Biotech Co., Ltd., Tainan 744, Taiwan.ORCID 0000-0003-3386-6313
Hsieh-Hsun HoDepartment of Research and Design, Glac Biotech Co., Ltd., Tainan 744, Taiwan.
Jui-Fen ChenDepartment of Research and Design, Glac Biotech Co., Ltd., Tainan 744, Taiwan.
Ko-Chiang HsiaDepartment of Research and Design, Glac Biotech Co., Ltd., Tainan 744, Taiwan.
Yu SunDepartment of Neurology, En Chu Kong Hospital, New Taipei City 237, Taiwan.ORCID 0000-0002-4656-7032
En Chu Kong Hospital · TW

Funding

grant from Glac Biotech Co., Ltd., Tainan, Taiwan no grant number
6 · The paper itself

Abstract

The role of neurotrophic factors, oxidative stress, and inflammation in the pathogenesis of Alzheimer's disease (AD) has been explored. Animal studies have reported the positive effects of probiotics on these factors. Some clinical studies also support the potential role of probiotics in improving cognitive function via the gut-brain axis in older adults. However, clinical experimental studies evaluating the efficacy of probiotics targeting the neurotrophic factors and inflammatory biomarkers, particularly among AD patients, remain very limited. In this randomized, double-blinded, active-controlled trial, we used multi-strain probiotic supplements, including

Indexed as

Alzheimer DiseaseProbioticsAgedBifidobacterium bifidumBifidobacterium longum subspecies infantisBiomarkersBrain-Derived Neurotrophic FactorCognitionDouble-Blind MethodHumansInflammationOxidative StressBiomarkersBrain-Derived Neurotrophic FactorAlzheimer’s diseaseanti-inflammationbrain-derived neurotrophic factor (BDNF)clinical trialcognitive functionoxidative stressprobiotics

Identifiers

PMID38201846
PMCPMC10780998
OpenAlexW4390006444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.